CCEL vs SLB · P/E 490, $39.6M cap vs P/E 12, rev $35.71B
CryoCell International Inc (CCEL) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
CCEL does not have a complete income-statement cache yet.
Latest reported SLB revenue for 2025-12-31 was $35.71B. Net income was $3.37B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
CCEL currently screens at market cap $39.6M and trailing P/E 490.0. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the CCEL and SLB stock pages for the full models.
Not investment advice.